| 451 | (1~{R},3~{S})-~{N}-(6,7-dimethoxy-2-oxidanylidene-chromen-3-yl)-3-[(phenylmethyl)amino]cyclohexane-1-carboxamide | N9T |
 |
1 |
| 452 | 1-[[4-[2-[4-[[4-(dimethylamino)pyridin-1-yl]methyl]phenoxy]ethoxy]phenyl]methyl]-N,N-dimethyl-pyridin-4-amine | NBR |
 |
1 |
| 453 | P-NITROPHENYL-PHOSPHOCHOLINE | NCH |
 |
1 |
| 454 | 7,9-DIMETHYLGUANINE | NDM |
 |
1 |
| 455 | ETHYL DIMETHYL AMMONIO PROPANE SULFONATE | NDS |
 |
1 |
| 456 | 2-(2-{[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]amino}ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione | NF1 |
 |
1 |
| 457 | 6-(dimethylamino)-2-(2-{[(5-methyl-1,3,4-thiadiazol-2-yl)methyl]amino}ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione | NF6 |
 |
1 |
| 458 | N-[(4-amino-2-methylpyrimidin-5-yl)methyl]formamide | NFM |
 |
1 |
| 459 | 3AR,5R,6S,7R,7AR-5-HYDROXYMETHYL-2-METHYL-5,6,7,7A-TETRAHYDRO-3AH-PYRANO[3,2-D]THIAZOLE-6,7-DIOL | NGT |
 |
1 |
| 460 | ethyl-dimethyl-(4-oxidanyl-4-oxidanylidene-butyl)azanium | NM3 |
 |
1 |
| 461 | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-azanyl-2-oxidanylidene-3~{H}-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid | NYZ |
 |
1 |
| 462 | [[(2~{R},3~{S},4~{R},5~{R})-5-(6-azanyl-2-diazanyl-purin-9-yl)-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid | O02 |
 |
1 |
| 463 | 4-[[5-[7-chloranyl-3-(1~{H}-indazol-6-yl)benzotriazol-5-yl]pyrazol-1-yl]methyl]benzenecarbonitrile | O1H |
 |
1 |
| 464 | 2-[4-(4-cyano-3-methylphenoxy)phenyl]-N-ethyl-N-[2-(1H-pyrazol-1-yl)ethyl]acetamide | OAV |
 |
1 |
| 465 | 3-(3-HYDROXY-BENZOYLOXY)-8-METHYL-8-AZA-BICYCLO[3.2.1]OCTANE-2-CARBOXYLIC ACID | OBE |
 |
1 |
| 466 | 2-[2-[[[(4~{R},8~{S},11~{S})-11-azanyl-8-[(4-hydroxyphenyl)methyl]-6,10-bis(oxidanylidene)-1,2-dithia-5,9-diazacyclotridec-4-yl]carbonylamino]methyl]phenyl]ethanoic acid | ONN |
 |
1 |
| 467 | 1-[(1S)-4-carbamimidamido-1-carboxybutyl]-5-oxo-D-proline | OP1 |
 |
1 |
| 468 | (2~{R})-2-(3-fluorophenyl)-5,5-dimethyl-morpholine | OUQ |
 |
1 |
| 469 | ~{N}-ethyl-2-[(2~{S},5~{R})-5-methyl-2-phenyl-morpholin-4-yl]ethanamine | OUZ |
 |
1 |
| 470 | (2~{R},5~{S})-2-(2-chlorophenyl)-5-methyl-morpholine | OWZ |
 |
1 |
| 471 | 3-[(2~{R},5~{S})-2-(2,5-dimethylphenyl)-5-methyl-morpholin-4-yl]propane-1-sulfonamide | OXB |
 |
1 |
| 472 | bn7GpppG mRNA 5' cap analog | OYE |
 |
1 |
| 473 | PIPERAZINE-N,N'-BIS(2-ETHANESULFONIC ACID) | PIN |
 |
1 |
| 474 | (3R,4R)-1-METHANESULFONYL-PYRROLIDINE-3,4-DICARBOXYLIC ACID 3-[(4-CHLORO-3-FLUORO-PHENYL)-AMIDE] 4-{[2-FLUORO-4-(2-OXO-2H-PYRIDIN-1-YL)-PHENYL]-AMIDE} | OYJ |
 |
1 |
| 475 | 6-[[(2-chloranyl-6-fluoranyl-phenyl)methyl-methyl-amino]methyl]-1~{H}-pyrimidine-2,4-dione | P0B |
 |
1 |
| 476 | 6-[[furan-2-ylmethyl(methyl)amino]methyl]-5~{H}-pyrimidine-2,4-dione | P0K |
 |
1 |
| 477 | (2~{R},3~{R})-2-(3-chlorophenyl)-3,5,5-trimethyl-morpholine | P0Q |
 |
1 |
| 478 | 6-[[methyl-[(1-phenylpyrazol-3-yl)methyl]amino]methyl]-1~{H}-pyrimidine-2,4-dione | P0W |
 |
1 |
| 479 | 3-[(2~{R})-5,5-dimethyl-2-phenyl-morpholin-4-yl]-~{N}-(methylcarbamoyl)propanamide | P0Z |
 |
1 |
| 480 | (3-endo)-N-(2-bromophenyl)-9-methyl-9-azabicyclo[3.3.1]nonan-3-amine | P1M |
 |
1 |
| 481 | 4-(4-BROMOPHENYL)PIPERIDIN-4-OL | UMK |
 |
1 |
| 482 | 1-[(2~{R},5~{S})-2-(3-chlorophenyl)-5-methyl-morpholin-4-yl]-3-methoxy-propan-2-ol | P1Q |
 |
1 |
| 483 | N-[(1-benzyl-1H-tetrazol-5-yl)methyl]-N-{[4-(hydroxycarbamoyl)phenyl]methyl}-2-(trifluoromethyl)benzamide | P5Y |
 |
1 |
| 484 | Resminostat | P7D |
 |
1 |
| 485 | 4-[({[(1R,2R,5R)-6,6-dimethylbicyclo[3.1.1]heptan-2-yl]methyl}amino)methyl]-N-hydroxybenzamide | P7J |
 |
1 |
| 486 | 2-(4-bromophenyl)-N-hydroxy-1,3-oxazole-4-carboxamide | P7V |
 |
1 |
| 487 | N-[(4-fluorophenyl)methyl]-1-[(1R)-1-naphthalen-1-ylethyl]piperidine-4-carboxamide | P85 |
 |
1 |
| 488 | 3-bromo-5-[(4-pyrrolidin-1-ylpiperidin-1-yl)carbonyl]pyridine | P8H |
 |
1 |
| 489 | (1-methylpiperidin-4-yl) 3-fluoranylbenzoate | S2V |
 |
1 |
| 490 | 2-[[[3-(5-methoxy-2-oxidanyl-phenyl)-5-sulfanylidene-1~{H}-1,2,4-triazol-4-yl]amino]methyl]benzoic acid | PJB |
 |
1 |
| 491 | (5aS,12aS,13aS)-12,12-dimethyl-2,3,11,12,12a,13-hexahydro-1H,5H,6H-5a,13a-(epiminomethano)indolizino[7,6-b]carbazol-14-one | PM7 |
 |
1 |
| 492 | 6-CHLORO-2-(1-FURO[2,3-C]PYRIDIN-5-YL-ETHYLSULFANYL)-PYRIMIDIN-4-YLAMINE | PNU |
 |
1 |
| 493 | (2E)-N-[2-(azepan-1-yl)ethyl]-2-(hydroxyimino)acetamide | PQV |
 |
1 |
| 494 | (2E,2'E)-N,N'-[1,4-diazepane-1,4-diyldi(ethane-2,1-diyl)]bis[2-(hydroxyimino)acetamide] | PQY |
 |
1 |
| 495 | THIENO[3,2-B]PYRIDINE-2-SULFONIC ACID [2-OXO-1-(1H-PYRROLO[2,3-C]PYRIDIN-2-YLMETHYL)-PYRROLIDIN-3-YL]-AMIDE | PR2 |
 |
1 |
| 496 | PTEROIC ACID | PT1 |
 |
1 |
| 497 | 4-(trifluoromethyl)pyrimidin-2-amine | PW7 |
 |
1 |
| 498 | 5-fluoro-1H-pyrrolo[2,3-b]pyridine | PWD |
 |
1 |
| 499 | 6-[[cyclopropyl-[(7-methoxy-1,3-benzodioxol-5-yl)methyl]amino]methyl]-1~{H}-pyrimidine-2,4-dione | QF2 |
 |
1 |
| 500 | 8-(2,6-dimethylpyridin-3-yl)-N-[(5-fluoro-2,3-dihydro-1-benzofuran-4-yl)methyl]-1-(methylsulfonyl)imidazo[1,5-c]pyrimidin-5-amine | Q3A |
 |
1 |